TIOTROPIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tiotropium, and what generic alternatives are available?
Tiotropium is a drug marketed by Lupin and is included in one NDA.
The generic ingredient in TIOTROPIUM is tiotropium bromide. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tiotropium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tiotropium
A generic version of TIOTROPIUM was approved as tiotropium bromide by LUPIN on June 20th, 2023.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TIOTROPIUM?
- What are the global sales for TIOTROPIUM?
- What is Average Wholesale Price for TIOTROPIUM?
Summary for TIOTROPIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for TIOTROPIUM |
| DailyMed Link: | TIOTROPIUM at DailyMed |
US Patents and Regulatory Information for TIOTROPIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin | TIOTROPIUM BROMIDE | tiotropium bromide | POWDER;INHALATION | 211287-001 | Jun 20, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |



